(Q24201038)

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

The Growth Restriction Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Prophylactic corticosteroids for preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

The classification and definition of the hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Reduced salt intake compared to normal dietary salt, or high intake, in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Plasma volume expansion for treatment of women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Altered dietary salt for preventing pre-eclampsia, and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Drugs for treatment of very high blood pressure during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Antiplatelet agents for preventing pre-eclampsia and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Interventions for treating pre-eclampsia and its consequences: generic protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Magnesium sulphate and other anticonvulsants for women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Expectant management of severe preeclampsia remote from term: a structured systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Magnesium supplementation in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Interventionist versus expectant care for severe pre-eclampsia before term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

7 January 2021

P46. TOTEM study (temporise or terminate pregnancy in women with severe preeclampsia at 28-34 weeks): A study protocol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

7 January 2021

Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

7 January 2021

Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003106.PUB2

7 January 2021